Physician profile
Marcello A Borzatta
NPI 1154368181
$8,147.92
in general payments reported to CMS, 2019-2025
16 companies · $1,791 in 2025
The $1,791 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $1,605 · 2021: $439 · 2022: $875 · 2023: $2,286 · 2024: $499 · 2025: $1,791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,851 · Travel and Lodging: $1,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,851.27 |
| Travel and Lodging | $1,724.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,816.46 | 2021-2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $1,798.37 | 2019-2023 | Viabahn Endoprosthesis With Propaten Bioactive Surface, Gore Viabahn Endoprosthesis |
| Angiodynamics, INC. | $1,070.61 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Bard Peripheral Vascular, INC. | $612.31 | 2019-2022 | |
| Cardiovascular Systems INC. | $249.42 | 2019-2023 | Diamondback Peripheral |
| Veryan Medical Incorporated | $119.07 | 2022 | |
| Medtronic, INC. | $117.19 | 2021-2023 | Venaseal |
| Getinge USA Sales, LLC | $96.82 | 2019-2021 | |
| Inari Medical, INC. | $84.48 | 2020-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $47.02 | 2025 | Xact |
| Silk Road Medical, INC. | $34.88 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Argon Medical Devices, INC. | $27.66 | 2022-2023 | Cleaner |
| Cook Medical LLC | $24.84 | 2020-2021 | |
| Mimedx Group, INC. | $19.37 | 2024 | |
| Biosense Webster, INC. | $15.07 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $14.35 | 2025 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcello Borzatta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.